{"id":499474,"date":"2020-07-29T13:44:01","date_gmt":"2020-07-29T13:44:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=499474"},"modified":"2020-07-29T13:44:01","modified_gmt":"2020-07-29T13:44:01","slug":"united-kingdom-diabetes-market-by-continuous-glucose-monitoring-cgm-blood-glucose-smbg-device-insulin-pen-insulin-pump-reimbursement-company-analysis-forecast","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/united-kingdom-diabetes-market-by-continuous-glucose-monitoring-cgm-blood-glucose-smbg-device-insulin-pen-insulin-pump-reimbursement-company-analysis-forecast_499474.html","title":{"rendered":"United Kingdom Diabetes Market, By Continuous Glucose Monitoring (CGM), Blood Glucose (SMBG) Device, Insulin Pen, Insulin Pump, Reimbursement Company Analysis & Forecast"},"content":{"rendered":"
\"United<\/a><\/p>\n
\n
Our core team is comprised of an experienced people holding graduate, post graduate and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research helps to make the business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them findings and perspectives across a wide range of markets.<\/div>\n<\/div>\n<\/div>\n
United Kingdom Diabetes Market is expected to reach USD 4.33 Billion by the year 2025. By Continuous Glucose Monitoring, Self Monitoring Blood Glucose Device, Insulin Pen & Pump Market, Companies Analysis<\/div>\n

Diabetes mellitus is a condition in which the amount of glucose in the blood is too high because the body cannot use it properly. There are two types of diabetes; Type 1 and Type 2. The most common of the two types is Type 2 diabetes and its accounts for around 90 per cent of people with diabetes in the United Kingdom. The market of Insulin Pen, Insulin Pump, Continuous Glucose Monitoring (CGM) Device and Self Monitoring Blood Glucose Device are growing due to the rising awareness for diabetes in the United Kingdom. United Kingdom Diabetes Market<\/strong><\/span><\/a> is expected to reach USD 4.33 Billion<\/strong> by the year 2025.<\/strong><\/p>\n

 <\/p>\n

\"\"<\/strong><\/p>\n

In the United Kingdom, there are more than a million people diagnosed with diabetes, and the number continues to grow. Diabetes is one of the biggest health challenges the United Kingdom is facing today. Growing health crisis and its complications will increase awareness of the risks, improve self-management among people with diabetes bring about wholesale changes in lifestyle and improve access to integrated diabetes care services.<\/p>\n

The National Service Framework (NSF) program is improving services by setting national standards to drive up service quality and tackle variations in care. In 2019, The Association of British HealthTech Industries (ABHI) had launched a diabetes section, enabling diabetes technology companies to work together in the first forum of its kind. ABHI group is for any health technology company with an interest in diabetes care from CGM and insulin pumps to apps.<\/p>\n

Renub Research report titled “United Kingdom Diabetes Market & Forecast, By Continuous Glucose Monitoring (CGM Market by Components, Glucose Sensor, Transmitter, CGM User, Reimbursement), Self Monitoring Blood Glucose Device Analysis (SMBG Market by, Test Strips, Lancet, Meter, Blood Glucose Device Users & Reimbursement) Insulin Pen Analysis – (User, Types – Disposable, Reusable and Smart Insulin Pen, Insulin Pen Needle Market, Reimbursement Policies), Insulin Pump Market, (Differentiation Points of Insulin Pump Products, Training Model for Patients & HCP, USA (By States) – Diabetes Supplies, Insulin Pump & Pump Supplies Reimbursement Policies by State-Sponsored Health Program) Companies (B. Braun Melsungen AG, Eli Lilly and Company, Artsana S.p.A, BD, Novo Nordisk A\/S, Owen Mumford Ltd, Ypsomed AG, Medtronic, Insulet Corporation, LifeScan Inc., Abbott Laboratories)”<\/p>\n

Request a free Sample copy of the report:<\/strong> https:\/\/www.renub.com\/request-sample-page.php?gturl=united-kingdom-diabetes-market-p.php<\/span><\/a><\/p>\n

 <\/p>\n

Segments Market based on Devices<\/strong><\/p>\n

1. Continuous Glucose Monitoring (CGM)
2. Self Monitoring Blood Glucose (SMBG)
3. Insulin Pen
4. Insulin Pump<\/p>\n

United Kingdom Diabetes Sub-Segment Analysis<\/strong><\/p>\n

1. Continuous Glucose Monitoring (CGM)<\/em><\/strong><\/p>\n

1. Glucose Sensor Market & Forecast
2. CGM Transmitter Market & Forecast
3. CGM User
4. CGM Reimbursement<\/p>\n

2. Self Monitoring Blood Glucose (SMBG)<\/strong><\/em><\/p>\n

1. Test Strips Market and Forecast
2. Lancet Market and Forecast
3. Meter Market and Forecast
4. Blood Glucose (SMBG) Users
5. Blood Glucose Devices Reimbursement<\/p>\n

3. Insulin Pen<\/strong><\/em><\/p>\n

1. Disposable Insulin Pen
2. Reusable Insulin Pen
3. Smart Insulin Pen
4. Insulin Pen Needle Market
5. Insulin Pen Users
6. Reimbursement Policies<\/p>\n

4. Insulin Pump<\/strong><\/em><\/p>\n

1. Insulin Pump Market
2. Insulin Pump Users
3. Reimbursement Policies<\/p>\n

All the 14 Companies Studied in the Report have been Studied from 3 Points<\/strong><\/p>\n

• Company Overview
• Recent Developments
• Financial Insight<\/p>\n

Company Analysis<\/strong><\/p>\n

1. B. Braun Melsungen AG
2. Eli Lilly and Company
3. Artsana S.p.A
4. BD
5. Novo Nordisk A\/S
6. Owen Mumford Ltd
7. Ypsomed AG
8. Medtronic
9. Insulet Corporation
10. LifeScan Inc.
11. Abbott Laboratories
12. Roche
13. Dexcom Inc<\/p>\n

Industry Related Opportunity:<\/strong><\/p>\n

United States Diabetes Market: https:\/\/www.renub.com\/united-states-diabetes-market-p.php<\/span><\/a><\/p>\n

Germany Diabetes Market: https:\/\/www.renub.com\/germany-diabetes-market-p.php<\/span><\/a><\/p>\n

About Company:<\/strong><\/p>\n

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises of major players in Life Sciences, Information Technology, Telecom, Financial Services (Banking, Insurance), Energy, Retail, Manufacturing, Automotive, and Social sector. Our clients rely on our market analysis and data to make informed knowledgeable decisions. We are regarded as one of the best providers of knowledge. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.<\/p>\n

Also Read: https:\/\/www.pressreleasepoint.com\/united-kingdom-diabetes-market-cgm-smbg-insulin-pen-pump-companies<\/span><\/a><\/p>\n

Contact Us:<\/strong>
Renub Research
Phone No: +1 678-302-0700 (USA) | +91-120-421-9822 (IND)
Email: info@renub.com
Web: https:\/\/www.renub.com
Follow on Linkedin: https:\/\/www.linkedin.com\/company\/renub-research<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Renub Research<\/a>
Contact Person:<\/strong> Rajat Gupta
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> 16783020700
City:<\/strong> Roswell
State:<\/strong> GA
Country:<\/strong> United States
Website:<\/strong> www.renub.com\/drugs-and-pharmaceuticals-13-c.php<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Our core team is comprised of an experienced people holding graduate, post graduate and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research helps to make the business decisions: on strategy, … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,410,406,403],"tags":[],"class_list":["post-499474","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-Manufacturing-Industry","category-Pharmaceuticals-Biotech","category-UK"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/499474","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=499474"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/499474\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=499474"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=499474"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=499474"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}